Column: The government could force a price cut for this prostate cancer drug by as much as 80%. Why hasn't it acted?

Los Angeles Times·Feb 10

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The government is reportedly considering a significant price cut for a prostate cancer drug, potentially up to 80%. However, it is unclear what action the government will take. The issue appears to be part of a broader discussion about government intervention in various sectors, including healthcare and the economy.

Full coverage

Column: Trump decries 'communism' while his government takes ownership of companies

Los Angeles Times·Jul 9

I wrote that Boomers were choking America’s economy. Their responses to me were revealing

Fortune·May 31

Florida’s property tax plan isn’t conservative governance — it’s fiscal roulette | Column

Yahoo·Jun 16

Opinion | If California forces state workers to commute, it passes up $225 million in savings. Can we afford that?

CalMatters·Mar 20

From free rider to innovator: How China became a global pharmaceutical powerhouse

CEPR·Apr 1

Fetching the latest headlines…